Clinical trialNo phase (not a drug trial)Withdrawn
QOL and GI Outcomes in Malignancies
Psychosocial Determinants of Health-Related Quality of Life (QOL) and Gastrointestinal (GI) Functional Outcomes During Treatment for Malignancies
- Outcome
- Stopped earlyWe have decided to withdraw this research study due to the receipt of funding for a similar study that aligns more closely with our current research priorities and available resources. (Business decision)
- Phase
- No phase (not a drug trial)
- Status
- Withdrawn
- Study type
- Interventional
- Planned start
- 1 October 2024
- Planned end
- 8 October 2024
- Enrollment
- 0 participants
- Sites
- 1
- Primary outcomes
- Health Related Quality of Life as Measured by Perceived Stress Scale; Health Related Quality of Life as Measured by University of California, Los Angeles (UCLA) Loneliness Scale; Health Related Quality of Life as Measured by Interpersonal Support Evaluation List; Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy General - 7 Item Version (FACT-G7); Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy (FACT) Hepatobiliary-Pancreatic Symptom Index (FHSI)-18
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 26 November 2024
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.